Medication
Ribavirin is one medication which has shown good potential for the treatment of hPIV-3 given recent in-vitro tests (in-vivo tests show mixed results). Ribavirin is a broadscale anti-viral and is currently being administered to those who are severely immuno-compromised, despite the lack of conclusive evidence for its use. Protein inhibitors and novel forms of medication have also been proposed to relieve the symptoms of infection.
Furthermore, antibiotics may be used if a secondary bacterial infection develops. Corticosteroid treatment and nebulizers and also a first line choice against croup if breathing difficulties ensue.
Read more about this topic: Human Parainfluenza Viruses